Sherlock debuts to develop CRISPR diagnostics with IP from Broad, Harvard

Broad Institute of MIT and Harvard launched CRISPR diagnostic company Sherlock on Thursday with $35 million in funding and exclusive licenses to platforms developed by CRISPR pioneer Feng Zhang and prominent synthetic

Read the full 325 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE